Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis B virus X protein (HBx) is a multifunctional, non-structural regulatory protein encoded by the hepatitis B virus (HBV). It is essential for viral replication and plays a significant role in HBV pathogenesis, including the development of hepatocellular carcinoma (HCC). HBx acts as a pleiotropic regulator affecting multiple host cellular processes, including transcriptional regulation, signal transduction, protein degradation, cell cycle regulation, and epigenetic regulation. It is found in both the cytoplasm and nucleus and is indispensable for initiating and maintaining efficient HBV replication. Due to its central role in promoting chronic infection persistence and driving oncogenic transformation of hepatocytes, it represents an attractive target for therapeutic intervention.
Not applicable; currently no approved drugs directly target HBx. Research efforts are focused on developing HBx inhibitors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B virus X protein (HBx).